colistimethate sodium has been researched along with Critical Illness in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (8.70) | 29.6817 |
2010's | 19 (82.61) | 24.3611 |
2020's | 2 (8.70) | 2.80 |
Authors | Studies |
---|---|
Benítez-Cano, A; Bermejo, S; Campillo, N; Carazo, J; de Antonio-Cuscó, M; Grau, S; Horcajada, JP; Luque, S; Ramos, I; Samsó, E; Sorlí, L | 1 |
Bhati, RK; Meshram, GG; Ram, K; Sheikh, S; Suri, JC; Tripathi, CD | 1 |
Bergen, PJ; Hua, X; Karaiskos, I; Kaye, KS; Li, C; Li, J; Pogue, JM; Sharma, VS; Song, J; Tsuji, BT; Zhu, Y | 1 |
Boisson, M; Cormier, M; Couet, W; Gobin, P; Grégoire, N; Marchand, S; Mimoz, O | 1 |
Alvarez-Lerma, F; Grau, S; Horcajada, JP; Luque, S; Segura, C; Sorlí, L; Valle, M | 1 |
Akajagbor, DS; Charurat, ME; Dakum, P; Gilliam, BL; Shere-Wolfe, KD; Wilson, SL | 1 |
Biancone, L; Bua, RO; Carignano, P; Leporati, M; Mariano, F; Stella, M; Vincenti, M | 1 |
Boisson, M; Couet, W; Gobin, P; Grégoire, N; Jacobs, M; Marchand, S; Mimoz, O | 1 |
Balayn, D; Chatelier, D; Comets, E; Couet, W; Gauzit, R; Gobin, P; Grégoire, N; Lasocki, S; Marchand, S; Mégarbane, B; Mimoz, O | 1 |
Baziaka, F; Friberg, LE; Galani, L; Giamarellou, H; Ioannidis, K; Karaiskos, I; Kostakou, E; Koutsoukou, A; Paskalis, C; Pontikis, K; Tsagkari, V | 1 |
Balayn, D; Couet, W; Gobin, P; Grégoire, N; Jacobs, M; Marchand, S; Mégarbane, B; Mimoz, O | 1 |
Abril-López de Medrano, V; Gimeno-Cardona, C; Ortega-García, MP | 1 |
Chokephaibulkit, K; Imberti, R; Nakwan, N; Regazzi, M; Usaha, S; Villani, P | 1 |
Anabtawi, N; Nazer, LH | 1 |
Antoniadou, A; Armaganidis, A; Cars, O; Friberg, LE; Giamarellou, H; Karaiskos, I; Karvanen, M; Kontopidou, F; Papadomichelakis, E; Plachouras, D; Poulakou, G; Tsangaris, I | 1 |
Baltopoulo, G; Boutzouka, E; Fousteri, M; Markantonis, SL; Markou, N; Tsigou, E | 1 |
Berenguer, N; Grau, S; Horcajada, JP; Luque, S; Montero, MM; Salas, E; Sorlí, L | 1 |
Forrest, A; Garonzik, SM; Jacob, J; Li, J; Nation, RL; Paterson, DL; Shoham, S; Silveira, FP; Thamlikitkul, V | 1 |
Bergen, PJ; Li, J; Nation, RL | 1 |
Brienza, N; Bruno, F; Coppolecchia, S; Dalfino, L; Miragliotta, G; Monno, R; Mosca, A; Puntillo, F; Spada, ML | 1 |
Baltopoulos, G; Boutzouka, E; Fousteri, M; Hroni, D; Markantonis, SL; Markou, N; Zidianakis, B | 1 |
Armaganidis, A; Cars, O; Friberg, LE; Giamarellou, H; Karaiskos, I; Karvanen, M; Papadomichelakis, E; Paramythiotou, E; Plachouras, D; Tsangaris, I | 1 |
Boots, R; Deans, R; Douglas, A; Li, J; Lipman, J; Nation, RL; Rayner, CR; Widdecombe, N | 1 |
3 review(s) available for colistimethate sodium and Critical Illness
Article | Year |
---|---|
Optimizing colistin dosing: Is a loading dose necessary?
Topics: Anti-Bacterial Agents; Colistin; Critical Illness; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Prodrugs; Treatment Outcome | 2017 |
[Shedding light on the use of colistin: still gaps to be filled].
Topics: Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Colistin; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Kidney Tubular Necrosis, Acute; Prospective Studies; Retrospective Studies | 2011 |
Dosing of colistin-back to basic PK/PD.
Topics: Animals; Anti-Bacterial Agents; Colistin; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Prodrugs | 2011 |
2 trial(s) available for colistimethate sodium and Critical Illness
Article | Year |
---|---|
Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.
Topics: Adult; Aged; Aged, 80 and over; Chromatography, Liquid; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Middle Aged; Tandem Mass Spectrometry | 2009 |
Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Critical Illness; Female; Humans; Male; Middle Aged; Young Adult | 2011 |
18 other study(ies) available for colistimethate sodium and Critical Illness
Article | Year |
---|---|
Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Critical Illness; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Prospective Studies | 2019 |
Steady-state pharmacokinetic and pharmacodynamic profiling of colistin in critically ill patients with multi-drug-resistant gram-negative bacterial infections, along with differences in clinical, microbiological and safety outcome.
Topics: Administration, Inhalation; Administration, Intravenous; Adult; Anti-Bacterial Agents; Colistin; Critical Illness; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Patient Safety; Predictive Value of Tests; Prospective Studies; Risk Assessment; Treatment Outcome; Young Adult | 2021 |
ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study.
Topics: Adult; Anti-Bacterial Agents; Colistin; Critical Illness; Humans; Mobile Applications | 2020 |
Pharmacokinetics of nebulized colistin methanesulfonate in critically ill patients.
Topics: Administration, Inhalation; Adult; Aerosols; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Critical Illness; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Hospitalization; Humans; Lung; Male; Middle Aged; Nebulizers and Vaporizers; Pneumonia, Ventilator-Associated | 2017 |
Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Colistin; Critical Illness; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Plasma; Pneumonia, Bacterial | 2013 |
Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Colistin; Critical Illness; Female; Humans; Incidence; Male; Middle Aged; Polymyxin B; Retrospective Studies; Tertiary Care Centers | 2013 |
Determination by LC-MS/MS of colistins A and B in plasma and ultrafiltrate from critically ill patients undergoing continuous venovenous hemodiafiltration.
Topics: Anti-Bacterial Agents; Chromatography, Liquid; Colistin; Critical Illness; Hemodiafiltration; Humans; Limit of Detection; Mass Spectrometry; Sensitivity and Specificity | 2014 |
Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients.
Topics: Administration, Inhalation; Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biotransformation; Colistin; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Extracellular Fluid; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Half-Life; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Pneumonia, Ventilator-Associated | 2014 |
New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationale.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Biotransformation; Colistin; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Half-Life; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged | 2014 |
Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Chromatography, Liquid; Colistin; Creatinine; Critical Illness; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Statistical; Tandem Mass Spectrometry | 2015 |
Population Pharmacokinetics of Colistin Methanesulfonate and Colistin in Critically Ill Patients with Acute Renal Failure Requiring Intermittent Hemodialysis.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Critical Illness; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Renal Dialysis; Respiratory Tract Infections | 2016 |
[Changes in the dosing of colistimethate sodium in critically ill patients].
Topics: Anti-Bacterial Agents; Bacterial Infections; Colistin; Critical Care; Critical Illness; Drug Resistance, Multiple, Bacterial; Humans | 2016 |
Pharmacokinetics of Colistin Following a Single Dose of Intravenous Colistimethate Sodium in Critically Ill Neonates.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Bacteremia; Colistin; Critical Illness; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Pneumonia, Bacterial; Prospective Studies | 2016 |
Colistin penetration in the alveolar lining fluid of critically ill patients treated with IV colistimethate sodium.
Topics: Bronchoalveolar Lavage Fluid; Colistin; Critical Illness; Humans; Injections, Intravenous; Pneumonia, Ventilator-Associated | 2011 |
High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Colistin; Critical Illness; Cross Infection; Female; Gram-Negative Bacterial Infections; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Sepsis; Treatment Outcome | 2012 |
Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Colistin; Critical Illness; Gram-Negative Bacterial Infections; Hemodiafiltration; Humans; Infusions, Intravenous; Intensive Care Units; Male; Metabolic Clearance Rate; Middle Aged; Sepsis; Serum; Time Factors | 2012 |
Colistin methanesulfonate and colistin pharmacokinetics in critically ill patients receiving continuous venovenous hemodiafiltration.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Colistin; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Female; Hemodiafiltration; Humans; Male; Microbial Sensitivity Tests; Middle Aged | 2013 |
Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration.
Topics: Colistin; Critical Illness; Female; Hemodiafiltration; Humans; Middle Aged; Pseudomonas aeruginosa | 2005 |